Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Miklogen is a topical combination pharmaceutical product developed and marketed by the Argentine company KLONAL Laboratorios. It is formulated as a cream containing three active ingredients: betamethasone (as 17-valerate), gentamicin (as sulfate), and miconazole (as nitrate). This combination is indicated for the treatment of various inflammatory dermatoses where secondary bacterial or fungal infections are present or suspected. Betamethasone, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive actions. Gentamicin is a broad-spectrum aminoglycoside antibiotic that offers bactericidal activity against common skin pathogens, including *Staphylococcus aureus* and *Pseudomonas aeruginosa*. Miconazole is an imidazole antifungal agent that disrupts fungal cell membrane integrity by inhibiting the synthesis of ergosterol. As a generic marketed product in Argentina, Miklogen is commonly used for conditions such as infected eczema, seborrheic dermatitis, and contact dermatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on betamethasone + gentamicin + miconazole.